Wells Fargo’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.14M | Buy |
126,953
+67,110
| +112% | +$2.72M | ﹤0.01% | 2212 |
|
|
2025
Q1 | $3.07M | Buy |
59,843
+2,839
| +5% | +$146K | ﹤0.01% | 2485 |
|
|
2024
Q4 | $3.16M | Buy |
57,004
+17,451
| +44% | +$966K | ﹤0.01% | 2467 |
|
|
2024
Q3 | $1.3M | Buy |
39,553
+26,070
| +193% | +$857K | ﹤0.01% | 3047 |
|
|
2024
Q2 | $366K | Buy |
13,483
+1,609
| +14% | +$43.7K | ﹤0.01% | 3770 |
|
|
2024
Q1 | $432K | Buy |
11,874
+2,011
| +20% | +$73.1K | ﹤0.01% | 3643 |
|
|
2023
Q4 | $200K | Buy |
9,863
+2,539
| +35% | +$51.4K | ﹤0.01% | 4081 |
|
|
2023
Q3 | $130K | Sell |
7,324
-2,365
| -24% | -$42K | ﹤0.01% | 4291 |
|
|
2023
Q2 | $175K | Buy |
9,689
+5,679
| +142% | +$103K | ﹤0.01% | 4419 |
|
|
2023
Q1 | $50.4K | Buy |
4,010
+1,067
| +36% | +$13.4K | ﹤0.01% | 4866 |
|
|
2022
Q4 | $43.1K | Sell |
2,943
-163
| -5% | -$2.39K | ﹤0.01% | 4624 |
|
|
2022
Q3 | $53K | Buy |
3,106
+61
| +2% | +$1.04K | ﹤0.01% | 4625 |
|
|
2022
Q2 | $45K | Sell |
3,045
-1,668
| -35% | -$24.7K | ﹤0.01% | 4805 |
|
|
2022
Q1 | $79K | Sell |
4,713
-2,941
| -38% | -$49.3K | ﹤0.01% | 5112 |
|
|
2021
Q4 | $172K | Sell |
7,654
-2,130
| -22% | -$47.9K | ﹤0.01% | 4974 |
|
|
2021
Q3 | $210K | Buy |
+9,784
| New | +$210K | ﹤0.01% | 4792 |
|
|
2021
Q2 | – | Sell |
-1,941
| Closed | -$63K | – | 7004 |
|
|
2021
Q1 | $63K | Sell |
1,941
-1,252
| -39% | -$40.6K | ﹤0.01% | 5357 |
|
|
2020
Q4 | $132K | Buy |
+3,193
| New | +$132K | ﹤0.01% | 5098 |
|